FDA Drug recall D-1542-2022
Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufa…
- FDA Drug
- Class II
- terminated
- Published 2022-10-05
On 2022-10-05 the FDA classified a Class II recall of Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufa… by Viatris, citing presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1542-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-09-21 |
| Published | 2022-10-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Viatris |
| Distribution | US |
Product
Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A
Reason
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
Identifiers
| code_info | Lot 7105130, exp 9/2023 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1542-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.